117 results match your criteria: "Lübeck Institute of Experimental Dermatology (LIED)[Affiliation]"

Predictive, integrative, and regulatory aspects of AI-driven computational toxicology - Highlights of the German Pharm-Tox Summit (GPTS) 2024.

Toxicology

December 2024

BASF SE, Experimentelle Toxikologie und Ökologie, Carl-Bosch-Straße, Ludwigshafen am Rhein 67056, Germany.

The 9th German Pharm-Tox Summit (GPTS) and the 90th Annual Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) took place in Munich from March 13-15, 2024. The event brought together over 700 participants from around the world to discuss cutting-edge developments in the fields of pharmacology and toxicology as well as scientific innovations and novel insights. A key focus of the conference was on the rapidly increasing role of computational toxicology, artificial intelligence (AI), and machine learning (ML) into the field, marking a shift away from traditional methods and allowing the reduction of animal testing as primary tool for toxicological risk assessment.

View Article and Find Full Text PDF
Article Synopsis
  • - The autoimmune skin disease epidermolysis bullosa acquisita (EBA) is driven by autoantibodies against type VII collagen, leading to severe blistering, and is influenced by immune cells and proteases like granzyme B (GzmB).
  • - Researchers tested a new GzmB inhibitor, SNT-6935, and found that it notably reduced skin damage caused by anti-COL7 antibodies in a lab model of EBA.
  • - The study suggests that while GzmB plays a crucial role in EBA's damage mechanism, other factors may also contribute, supporting GzmB as a potential treatment target for EBA and similar diseases.
View Article and Find Full Text PDF

Medicinal polypharmacology is one answer to the complex reality of multifactorial human diseases that are often unresponsive to single-targeted treatment. It is an admittance that intrinsic feedback mechanisms, crosstalk, and disease networks necessitate drugs with broad modes-of-action and multitarget affinities. Medicinal polypharmacology grew to be an independent research field within the last two decades and stretches from basic drug development to clinical research.

View Article and Find Full Text PDF
Article Synopsis
  • The main part of BP180 that causes problems in certain skin diseases, like bullous pemphigoid (BP) and mucous membrane pemphigoid (MMP), is called NC16A, which is attacked by autoantibodies.
  • Most tests can find these autoantibodies in BP patients (80-90%), but only half of MMP patients have them.
  • This study discovered other parts of BP180 that can also be recognized by autoantibodies, which could help in creating better tests for people who don’t have the NC16A antibodies.
View Article and Find Full Text PDF
Article Synopsis
  • Fetal sex development in humans is controlled by genetic and hormonal switches that determine gonadal sex (testis or ovary) and influence the resulting sexual characteristics, though these processes are more complex than a binary system suggests.
  • Recent findings show that mutations can impact these switches variably, leading to a spectrum of differences in biological sex development (DSD), rather than strictly male or female phenotypes.
  • Key hormones like testosterone and Anti-Müllerian Hormone (AMH) play crucial roles in developing male characteristics and preventing the formation of female reproductive structures, highlighting the importance of hormonal receptors in these processes.
View Article and Find Full Text PDF

Background: Bullous pemphigoid (BP), the most common subepidermal autoimmune blistering disease, is classically defined by the presence of IgG autoantibodies directed against the hemidesmosomal proteins BP180 (type XVII collagen) and BP230 and the predominance of skin lesions. Several studies have addressed the role of anti-BP180 IgE in patients and experimental models, while data on anti-BP230 IgE are scarce.

Objective: To assess anti-BP230 IgE level by ELISA in BP sera and to correlate it with disease severity and clinical characteristics.

View Article and Find Full Text PDF

Limited studies have explored pemphigus variations among different ethnic groups residing in their respective geographical locations. This bicontinental study aimed to compare clinical and immunological parameters in Indian and European pemphigus patients in complete remission, off therapy, or on minimal therapy. 105 patients (India, n= 75; Bulgaria, n=15; Greece, n=15) with pemphigus vulgaris (PV) or pemphigus foliaceous (PF) in complete remission on minimal therapy (n=64) or complete remission off therapy (n=41) were recruited.

View Article and Find Full Text PDF
Article Synopsis
  • Linear IgA Dermatosis (LAD) is a rare autoimmune skin disease characterized by IgA deposits at the skin's basement membrane, affecting both children and adults with diverse clinical features.
  • The European Academy of Dermatology and Venereology (EADV) developed consensus guidelines by collaborating with 29 experts across multiple countries to ensure a comprehensive approach to diagnosis and treatment.
  • The resulting guidelines provide a combination of evidence-based and expert-based recommendations to aid dermatologists in effectively diagnosing and managing LAD.
View Article and Find Full Text PDF

Medicinal Polypharmacology in the Clinic - Translating the Polypharmacolome into Therapeutic Benefit.

Pharm Res

March 2024

Medicinal Chemistry and Systems Polypharmacology, Medical Systems Biology Division, Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck and University Medical Center Schleswig-Holstein, Ratzeburger Allee 160, 23538, Lübeck, Germany.

Drugs with multiple targets, often annotated as 'unselective', 'promiscuous', 'multitarget', or 'polypharmacological', are widely considered in both academic and industrial research as a high risk due to the likelihood of adverse effects. However, retrospective analyses have shown that particularly approved drugs bear rich polypharmacological profiles. This raises the question whether our perception of the specificity paradigm ('one drug-one target concept') is correct - and if specifically multitarget drugs should be developed instead of being rejected.

View Article and Find Full Text PDF
Article Synopsis
  • Pemphigus foliaceus (PF) is an autoimmune skin disease caused by the production of antibodies against desmoglein-1, with a specific endemic form (EPF) prevalent in Brazil.
  • A study examined the genetic relationship between histone (de)acetylation-related genes and EPF, identifying certain genetic variants that increase or decrease susceptibility to the disease.
  • Additionally, RNA sequencing revealed altered expression levels of specific genes in CD4 T lymphocytes from untreated EPF patients, suggesting these genes may play a role in immune response and disease pathology.
View Article and Find Full Text PDF

P-glycoprotein (P-gp, encoded in humans by the gene and in rodents by the genes) is a membrane transporter that can restrict the intestinal absorption and tissue distribution of many drugs and may also contribute to renal and hepatobiliary drug excretion. The aim of this study was to compare the performance and sensitivity of currently available radiolabeled P-gp substrates for positron emission tomography (PET) with the single-photon emission computed tomography (SPECT) radiotracer [Tc]Tc-sestamibi for measuring the P-gp function in the kidneys and liver. Wild-type, heterozygous (), and homozygous () knockout mice were used as models of different P-gp abundance in excretory organs.

View Article and Find Full Text PDF

Bullous pemphigoid (BP) is an autoimmune blistering disease that primarily affects the elderly. An altered skin microbiota in BP was recently revealed. Accumulating evidence points toward a link between the gut microbiota and skin diseases; however, the gut microbiota composition of BP patients remains largely underexplored, with only one pilot study to date, with a very limited sample size and no functional profiling of gut microbiota.

View Article and Find Full Text PDF

HD_BPMDS: a curated binary pattern multitarget dataset of Huntington's disease-targeting agents.

J Cheminform

November 2023

Drug Development and Chemical Biology, Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck and University Medical Center Schleswig-Holstein, Ratzeburger Allee 160, 23538, Lübeck, Germany.

The discovery of both distinctive lead molecules and novel drug targets is a great challenge in drug discovery, which particularly accounts for orphan diseases. Huntington's disease (HD) is an orphan, neurodegenerative disease of which the pathology is well-described. However, its pathophysiological background and molecular mechanisms are poorly understood.

View Article and Find Full Text PDF

At the core of complex and multifactorial human diseases, such as cancer, metabolic syndrome, or neurodegeneration, are multiple players that cross-talk in robust biological networks which are intrinsically resilient to alterations. These multifactorial diseases are characterized by sophisticated feedback mechanisms which manifest cellular imbalance and resistance to drug therapy. By adhering to the specificity paradigm ("one target-one drug concept"), research focused for many years on drugs with very narrow mechanisms of action.

View Article and Find Full Text PDF

Autoimmunity against laminin 332.

Front Immunol

August 2023

Lübeck Institute of Experimental Dermatology (LIED), University of Lübeck, Lübeck, Germany.

Laminin 332 is a heterotrimeric structural protein of the basal membrane zone (BMZ) of the skin and adjacent mucosal tissues. The importance of laminin 332 for the structural integrity of the BMZ is demonstrated by mutations in any of the three genes encoding for its three chains causing variants of junctional epidermolysis bullosa. Autoimmunity against laminin 332 is observed in mucous membrane pemphigoid (MMP) and in the rare patients with orf-induced pemphigoid.

View Article and Find Full Text PDF

Mucous membrane pemphigoid is an autoimmune blistering disorder characterized by predominant involvement of surface-close epithelia and linear depositions of immunoreactants at the dermal-epithelial junction on direct immunofluorescence microscopy. A major diagnostic difficulty is the frequent need for multiple biopsies to facilitate the diagnosis. Although oesophageal involvement is a rare, but life-threatening manifestation, the relevance of oesophageal direct immunofluorescence sampling is unclear.

View Article and Find Full Text PDF

Human skin equivalents (HSEs) are three-dimensional skin organ culture models raised in vitro. This review gives an overview of common techniques for setting up HSEs. The HSE consists of an artificial dermis and epidermis.

View Article and Find Full Text PDF

ABC Transporter C1 Prevents Dimethyl Fumarate from Targeting Alzheimer's Disease.

Biology (Basel)

June 2023

Department of Pathology, Section of Neuropathology/Translational Neurodegeneration Research and Neuropathology Lab, University of Oslo (UiO) and Oslo University Hospital (OUS), Sognsvannsveien 20, 0372 Oslo, Norway.

Alzheimer's disease (AD), the leading cause of dementia, is a growing health issue with very limited treatment options. To meet the need for novel therapeutics, existing drugs with additional preferred pharmacological profiles could be recruited. This strategy is known as 'drug repurposing'.

View Article and Find Full Text PDF

Impact of COVID-19 in patients with autoimmune bullous diseases: Report from an international registry.

J Eur Acad Dermatol Venereol

October 2023

Department of Dermatology, UMCG Center of Expertise for Blistering Diseases, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

View Article and Find Full Text PDF

Introduction: The function of the second receptor for the complement cleavage product C5a, C5aR2, is poorly understood and often neglected in the immunological context. Using mice with a global deficiency of , we have previously reported an important role of this receptor in the pathogenesis of the neutrophil-driven autoimmune disease (EBA). Based on analyses, we hypothesized that the absence of C5aR2 specifically on neutrophils is the cause of the observed differences.

View Article and Find Full Text PDF

Autoimmune blistering diseases (AIBD) are paradigms of autoantibody-mediated organ-specific autoimmune disorders that involve skin and/or mucous membranes. Compared to other autoimmune diseases, the pathogenicity of autoantibodies in AIBD is relatively well described. Pemphigus is a potentially lethal autoantibody driven autoimmune disorder with a strong HLA class II association.

View Article and Find Full Text PDF